Table 1 Cohort characteristics of esophageal cancer patients
Clinicopathological characteristics | eEF2 protein expression level | ||
|---|---|---|---|
Low (n = 50) | High (n = 50) | P | |
Gender | |||
 Male | 33 (66%) | 40 (80%) | 0.010 |
 Female | 17 (34%) | 10 (20%) |  |
Age | |||
  ≤ 60 | 16 (32%) | 16 (32%) | 0.672 |
  > 60 | 33 (66%) | 34 (68%) |  |
Histological grade | |||
 I | 11 (22%) | 5 (10%) | 0.176 |
 II | 33 (66%) | 39 (78%) |  |
 III | 6 (12%) | 6 (12%) |  |
Clinical stage | |||
 1 | 3 (6.0%) | 3 (6.0%) | 0.019 |
 2 | 26 (52%) | 16 (32%) |  |
 3 | 21 (42%) | 28 (56%) |  |
 Tumor size(mm3) (Mean ± SD) | 22.53 ± 3.621 | 25.83 ± 3.92 | 0.538 |
 Lymph node (Mean ± SD) Positive lymph node | 8.09 ± 0.81 | 8.47 ± 1.02 | 0.771 |
  (Mean ± SD) | 1.83 ± 0.45 | 1.52 ± 0.23 | 0.548 |